Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Medical Microbiology and Immmunology

• Publication date

  2014-02-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00430-014-0329-2PMID 24553842
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma.

  2013cited by this paper
• Novel insights into the biology of interleukin-32

  2013cited by this paper
• Inducible Interleukin 32 (IL-32) Exerts Extensive Antiviral Function via Selective Stimulation of Interferon λ1 (IFN-λ1)*

  2013cited by this paper
• Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C

  2013cited by this paper
• The expression of interleukin-32 is activated by human cytomegalovirus infection and down regulated by hcmv-miR-UL112-1

  2013cited by this paper
• IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis

  2013cited by this paper
• Infection: The interferon paradox

  2013cited by this paper
• HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.

  2012cited by this paper
• Increased interleukin-32 expression in chronic hepatitis B virus-infected liver.

  2012cited by this paper
• Differential expression of interleukin‐32 in chronic rhinosinusitis with and without nasal polyps

  2012cited by this paper
• Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection.

  2012cited by this paper
• IFN-λ inhibits HIV-1 integration and post-transcriptional events in vitro, but there is only limited in vivo repression of viral production.

  2012cited by this paper
• Innate immune interferon responses to Human immunodeficiency virus‐1 infection

  2012cited by this paper
• Interleukin‐32: A new proinflammatory cytokine involved in hepatitis C virus‐related liver inflammation and fibrosis

  2011cited by this paper
• Protection from RNA and DNA Viruses by IL-32

  2011cited by this paper
• Human MxA Protein: An Interferon-Induced Dynamin-Like GTPase with Broad Antiviral Activity

  2011cited by this paper
• The Immunosuppressive Role of IL-32 in Lymphatic Tissue during HIV-1 Infection

  2011cited by this paper
• Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.

  2011cited by this paper
• Inflammation-dependent secretion and splicing of IL-32γ in rheumatoid arthritis

  2011cited by this paper
• Activation of the interleukin‐32 pro‐inflammatory pathway in response to human papillomavirus infection and over‐expressionof interleukin‐32 controls the expression of the humanpapillomavirus oncogene

  2011cited by this paper
• Interleukin-32γ Enhances the Production of IL-6 and IL-8 in Fibroblast-Like Synoviocytes Via Erk1/2 Activation

  2010cited by this paper
• IL-32: A Host Proinflammatory Factor against Influenza Viral Replication Is Upregulated by Aberrant Epigenetic Modifications during Influenza A Virus Infection

  2010influential reference
• Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha

  2010cited by this paper
• IL-32 Is a Host Protective Cytokine against Mycobacterium tuberculosis in Differentiated THP-1 Human Macrophages

  2010cited by this paper
• Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction

  2010cited by this paper
• Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus

  2010cited by this paper
• Interferon-Lambda: A New Addition to an Old Family

  2010cited by this paper
• Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics

  2010cited by this paper
• Gene Expression of Nucleic Acid-Sensing Pattern Recognition Receptors in Children Hospitalized for Respiratory Syncytial Virus-Associated Acute Bronchiolitis

  2009cited by this paper
• Interleukin-32 Expression in the Pancreas

  2009cited by this paper
• Lambda Interferon Inhibits Human Immunodeficiency Virus Type 1 Infection of Macrophages

  2009cited by this paper
• Identification of the most active interleukin‐32 isoform

  2009cited by this paper
• IL-32–dependent effects of IL-1β on endothelial cell functions

  2009cited by this paper
• Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication.

  2008cited by this paper
• Retrovirology BioMed Central Review HIV-1 Vif, APOBEC, and Intrinsic Immunity

  2008cited by this paper
• Endogenous IL-32 Controls Cytokine and HIV-1 Production1

  2008cited by this paper
• Proteinase 3-processed form of the recombinant IL-32 separate domain.

  2008cited by this paper
• Genotypic Resistance of Archived and Circulating Viral Strains in the Blood of Treated HIV-Infected Individuals

  2007cited by this paper
• Proteinase 3 is an IL-32 binding protein.

  2006cited by this paper
• IL-32, a novel cytokine with a possible role in disease

  2006cited by this paper
• Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-γ-Dependent Mechanism

  2006cited by this paper
• IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism.

  2005cited by this paper
• Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication

  2004cited by this paper
• Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

  2002cited by this paper
• Faculty Opinions recommendation of Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

  2002cited by this paper

• Interleukin-32: a Pandora’s box in human immunodeficiency virus infection

  2025cites this paper
• Delving deeper into the mechanisms fundamental to HIV-associated immunopathology using single-cell sequencing techniques: A scoping review of current literature

  2024cites this paper
• Single-Cell Sequencing Facilitates Elucidation of HIV Immunopathogenesis: A Review of Current Literature

  2022cites this paper
• PARACOCCIDIOIDES brasiliensis induces IL-32 and is controlled by IL-15/IL-32/vitamin D pathway in vitro.

  2021cites this paper
• Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans

  2021cites this paper
• Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A

  2021cites this paper
• The CD8+ T Cell Noncytotoxic Antiviral Responses

  2021cites this paper
• Interleukin-32 in Infection, Inflammation and Cancer Biology

  2020cites this paper
• Influence of Systemic Inflammatory Response to Appearance of New Foci of Chronic Inflammation

  2020cites this paper
• Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients.

  2019cites this paper
• Elite control of HIV is associated with distinct functional and transcriptional signatures in lymphoid tissue CD8+ T cells

  2019cites this paper
• The role of interleukin-32 in infections caused by New World Leishmania species and identification of novel treatment strategies

  2019cites this paper
• Allele-specific long-distance regulation dictates IL-32 isoform switching and mediates susceptibility to HIV-1

  2018cites this paper
• Interleukin-32: An endogenous danger signal or master regulator of intracellular pathogen infections-Focus on leishmaniases.

  2018cites this paper
• Dendritic Cell–Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function

  2017cites this paper
• Comparative transcriptome analysis of PBMC from HIV patients pre- and post-antiretroviral therapy

  2017cites this paper
• The urinary and serum levels of IL-32 in children with febrile urinary tract infections

  2017cites this paper
• Interleukin 32: a novel player in the control of infectious diseases

  2017cites this paper
• IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection

  2016cites this paper
• Étude du rôle de l'interleukine-32 dans l'infection à VIH-1

  2016influential citation
• Molecular mechanisms and effector functions of the human cathelicidin host defence peptide LL-37: modulation of cytokine IL-32γ-induced responses and inflammatory arthritis

  2016influential citation
• Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors

  2016cites this paper
• Important Role of the IL-32 Inflammatory Network in the Host Response against Viral Infection

  2015cites this paper
• The innate immune roles of host factors TRIM5α and Cyclophilin A on HIV-1 replication

  2015cites this paper
• Variation in interferon sensitivity and induction between Usutu and West Nile (lineages 1 and 2) viruses.

  2015cites this paper
• Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice

  2015cites this paper
• MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients

  2015cites this paper
• Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients

  2015cites this paper
• Vaccination against infectious diseases: What is promising?

  2014cites this paper